Page 22 - 南京医科大学自然版
P. 22

第45卷第11期
               ·1552 ·                           南 京    医 科 大 学 学         报                        2025年11月


                         A
                                      shNC                      shKIF11⁃1
                                                                                          HCT116
                            10 Q1             Q2        10 Q1             Q2        50     ***
                              5
                                                         5
                               3.10%        7.41%          4.03%       15.4%
                                                                                    (%)  40
                                                         4
                              4
                            10                          10
                              3                          3                          30
                            10                          10                          Apoptotic rate  20
                            10 2                        10 2
                               Q4             Q3           Q4             Q3        10
                             0                           0
                           -10 2 78.9%      10.6%      -10 2 51.5%     29.1%         0
                                 0    10 3  10 4  10 5      0    10 3  10 4  10 5       shNC shKIF11⁃1
                                                         5
                              5
                            10 Q1             Q2        10 Q1             Q2        50    DLD1
                                                                                           ***
                               3.09%        9.06%          4.86%       16.2%
                                                                                    (%)  40
                              4
                                                         4
                            10                          10
                            10 3                        10 3                        Apoptotic rate  30
                                                                                    20
                            10 2                        10 2
                               Q4             Q3           Q4             Q3        10
                             0                           0
                           -10 2 77.9%      9.94%      -10 2 51.0%     27.9%         0
                                 0    10 3  10 4  10 5      0    10 3  10 4  10 5       shNC shKIF11⁃1
                         B            oe⁃NC                     oe⁃KIF11
                              5
                                                         5
                            10 Q1             Q2        10 Q1             Q2        15    SW480
                               0.41%        6.90%          0.27%       3.72%               **
                              4                          4                          (%)
                            10                          10                          10
                            10 3                        10 3                        Apoptotic rate
                            10 2                        10 2                         5
                               Q4             Q3           Q4             Q3
                             0                           0
                               88.2%        4.51%          92.2%       3.81%
                                                                                     0
                                       3   4    5                  3   4   5
                                 0    10  10  10            0    10  10  10             oe⁃NC oe⁃KIF11
                 A:Flow cytometry assays were performed to observe the percentage change of apoptosis cells after knockdown KIF11. B:Flow cytometry assays
                                                                          **
              were performed to observe the percentage change of apoptosis cells after overexpressing KIF11. P < 0.01 and  *** P < 0.001(n=3).
                                                图3 KIF11表达影响CRC细胞凋亡
                                       Figure 3 KIF11 expression affected apoptosis in CRC cells
                                                                                 [10]
              KIF11 stability through IGF2BP2 ⁃ dependent mecha⁃  with poor prognosis  . GEPIA database showed that
              nisms                                             METTL3 was positively correlated with KIF11 expres⁃
                  To explore potential mechanisms regulating    sion(Figure 5C). We verified that METTL3 positively
              KIF11 expression,we employed the starBase database  regulated KIF11 by qRT ⁃ PCR and WB experiments
             (https://rnasysu.com/encori/)and the STRING website  (Figure 5D-G). To verify whether KIF11 mRNA was
             (https://cn.string ⁃ db.org/)to conduct an enrichment  subject to METTL3 ⁃ mediated m6A modification,we
              analysis of RNA binding proteins(RBPs)connected   performed MeRIP⁃qPCR,and the results revealed that
              with KIF11 mRNA. The results demonstrated a strong  the m6A abundance of KIF11 mRNA was significantly
              correlation between m6A modification and KIF11    reduced after METTL3 knockdown(Figure 6A). The
              mRNA(Figure 5A). Subsequently,we use the SRAMP    above results suggest that METTL3 mediates the m6A
              website(http://www.cuilab.cn/sramp/)to confirm the  methylation modification of KIF11. Furthermore,we
              existence of several potentially high ⁃ confidence m6A  found that KIF11 mRNA stability was decreased after
              modification sites in the KIF11 mRNA(Figure 5B).  the knockdown of METTL3(Figure 6B,C). Overall,
              The online prediction site(http://m6a2target.cancer⁃  METTL3 induced KIF11 m6A modification and stabi⁃
              omics.org)revealed that METTL3 mediated the m6A   lized its expression. The current consensus indicates
              modification of KIF11. According to previous research,  that the m6A modifications function primarily by re⁃

              METTL3 was highly expressed in CRC and associated  cruiting“reader”proteins. Earlier research has report⁃
   17   18   19   20   21   22   23   24   25   26   27